SCOPUS 정보 검색 플랫폼 - 논문 보기

메뉴 건너뛰기

Journal of the National Cancer Institute

Volumn 92, Issue 17, 2000, Pages 1434-1436

Calvert's formula for dosing carboplatin: Overview and concerns of applicability in high-dose setting

(4) Mazumdar, Madhu a Smith, Alex a Tong, William P a Motzer, Robert J a

a MEMORIAL SLOAN KETTERING CANCER CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN;

AREA UNDER THE CURVE; ARTICLE; DOSE CALCULATION; DOSE KIDNEY FUNCTION RELATION; GLOMERULUS FILTRATION RATE; MATHEMATICAL MODEL; PRIORITY JOURNAL;

EID: 0034612769 PISSN: 00278874 EISSN: None Source Type: Journal
DOI: 10.1093/jnci/92.17.1434 Document Type: Article

Times cited : (14)

References (17)

1
- 0024440650
- Carboplatin dosage: Prospective evaluation of a simple formula based on renal function
- (1989) J Clin Oncol , vol.7 , pp. 1748-1756
- Calvert, A.H.¹ Newell, D.R.² Gumbrell, L.A.³ O'Reilly, S.⁴ Burnell, M.⁵ Boxall, F.E.⁶

2
- 0007992601
- Applied linear statistical models. 3rd ed. Homewood (IL): Richard D. Irwin, Inc.
- (1990) , pp. 21-85
- Neter, J.¹ Wasserman, W.² Kutner, M.H.³

3
- 0031256076
- A phase II study of repetitive cycles of dose-intense carboplatin plus paclitaxel chemotherapy and peripheral blood stem cells in metastatic breast cancer
- (1997) Semin Oncol , vol.24 , Issue.5 SUPPL. 17
- Ford, C.¹ Spitzer, G.² Reilly, W.³ Adkins, D.⁴

4
- 7144228608
- Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group
- (1998) J Clin Oncol , vol.16 , pp. 2426-2434
- Gore, M.¹ Mainwaring, P.² A'Hern, R.³ MacFarlane, V.⁴ Slevin, M.⁵ Harper, P.⁶

5
- 0030610497
- Phase I study of paclitaxel on a 3-hour schedule followed by carboplatin in untreated patients with stage IV non-small cell lung cancer
- (1997) Invest New Drugs , vol.15 , pp. 129-138
- Rowinsky, E.K.¹ Flood, W.A.² Sartorius, S.E.³ Bowling, K.M.⁴ Ettinger, D.S.⁵

6
- 0032936717
- Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: Effect on drug-plasma AUC and peripheral blood drug-DNA adduct levels
- (1999) Ann Oncol , vol.10 , pp. 329-334
- Ghazal-Aswad, S.¹ Tilby, M.J.² Lind, M.³ Baily, N.⁴ Sinha, D.P.⁵ Calvert, A.H.⁶ Newell, D.R.⁷

7
- 0032978689
- Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer
- (1999) J Clin Oncol , vol.17 , pp. 676-684
- Belani, C.P.¹ Kearns, C.M.² Zuhowski, E.G.³ Erkmen, K.⁴ Hiponia, D.⁵ Zacharski, D.⁶

8
- 0029098178
- Paclitaxel and carboplatin in the treatment of advanced non-small-cell lung cancer: A phase II toxicity, response, and survival analysis
- (1995) J Clin Oncol , vol.13 , pp. 1860-1870
- Langer, C.J.¹ Leighton, J.C.² Comis, R.L.³ O'Dwyer, P.J.⁴ McAleer, C.A.⁵ Bonjo, C.A.⁶

9
- 0028982557
- A pharmacologically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer
- (1995) Cancer Chemother Pharmacol , vol.35 , pp. 391-396
- Chatelut, E.¹ Chevreau, C.² Brunner, V.³ Martinez, M.⁴ Houin, G.⁵ Bugat, R.⁶

10
- 0032169734
- The clinical development of paclitaxel and the paclitaxel/carboplatin combination
- (1998) Eur J Cancer , vol.34 , pp. 1543-1548
- Schwartz, G.N.¹ Pendyala, L.² Kindler, H.³ Meropol, N.⁴ Perez, R.⁵ Raghavan, D.⁶

11
- 0031856187
- Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: A comparison of the performance of three formulae
- (1998) Cancer Chemother Pharmacol , vol.42 , pp. 307-312
- Okamoto, H.¹ Nagatomo, A.² Kunitoh, H.³ Kunikane, H.⁴ Watanabe, K.⁵

12
- 0030986627
- Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer
- (1997) J Clin Oncol , vol.15 , pp. 1953-1964
- Huizing, M.T.¹ Van Warmerdam, L.J.² Rosing, H.³ Schaefers, M.C.⁴ Lai, A.⁵ Helmerhorst, T.J.⁶

13
- 0029845033
- A phase I study of gemcitabine and carboplatin in non-small cell lung cancer
- (1996) Semin Oncol , vol.23 , Issue.5 SUPPL. 10 , pp. 55-59
- Carmichael, J.¹ Allerheiligen, S.² Walling, J.³

14
- 0029921559
- Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell support
- (1996) Br J Cancer , vol.73 , pp. 979-984
- Van Warmerdam, L.J.¹ Rodenhuis, S.² Van der Wall, E.³ Maes, R.A.⁴ Beijnen, J.H.⁵

15
- 0029655943
- Evaluation of formulas using the serum creatinine level to calculate the optimal dosage of carboplatin
- (1996) Cancer Chemother Pharmacol , vol.37 , pp. 266-270
- Van Warmerdam, L.J.¹ Rodenhuis, S.² Ten Bokkel Huinink, W.W.³ Maes, R.A.⁴ Beijnen, J.H.⁵

16
- 0023472526
- Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin
- (1987) Eur J Cancer Clin Oncol , vol.23 , pp. 1399-1405
- Newell, D.R.¹ Siddik, Z.H.² Gumbrell, L.A.³ Boxall, F.E.⁴ Gore, M.E.⁵ Smith, I.E.⁶

17
- 0034018301
- Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients
- (2000) J Clin Oncol , vol.18 , pp. 1173-1180
- Motzer, R.J.¹ Mazumdar, M.² Scheinfeld, J.³ Bajorin, D.F.⁴ Macapinlac, H.A.⁵ Bains, M.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.